Drug Profile
Imexon - Heidelberg Pharma
Alternative Names: AOP 99.0001; AOP-990001Latest Information Update: 13 Oct 2017
Price :
$50
*
At a glance
- Originator Heidelberg Pharma
- Class Antineoplastics; Antivirals; Hexanones; Small molecules
- Mechanism of Action Apoptosis stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Multiple myeloma
Most Recent Events
- 09 Oct 2017 Heidelberg Pharma is now called Heidelberg Pharma Research
- 31 Aug 2004 Phase-I/II clinical trials in Multiple myeloma in Austria (IV)
- 31 Aug 2004 Phase-I/II clinical trials in Multiple myeloma in Russia (IV)